{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T21:00:24Z","timestamp":1787950824633,"version":"build-2784847793"},"reference-count":13,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurology"],"published-print":{"date-parts":[[1997,1]]},"DOI":"10.1212\/wnl.48.1.91","type":"journal-article","created":{"date-parts":[[2012,5,13]],"date-time":"2012-05-13T13:26:01Z","timestamp":1336915561000},"page":"91-94","source":"Crossref","is-referenced-by-count":71,"title":["Anticardiolipin Antibodies and the Risk of Recurrent Thrombo-occlusive Events and Death"],"prefix":"10.1212","volume":"48","member":"276","reference":[{"key":"e_1_3_2_2_2","first-page":"2","volume":"43","year":"1993","unstructured":"The Antiphospholipid Antibodies in Stroke Study (APASS) Group. Anticardiolipin antibodies are an independent risk factor for first ischemic stroke. Neurology 1993;43:2069-2073.","journal-title":"Neurology"},{"key":"e_1_3_2_3_2","first-page":"4","volume":"339","year":"1992","unstructured":"Sletnes KE, Smith P, Abdelnoor M, Arnesen H, Wisloff F. Antiphospholipid antibodies after myocardial infarction and their relation to mortality, reinfarction, and nonhaemorrhagic stroke. Lancet 1992;339:451-453.","journal-title":"Lancet"},{"key":"e_1_3_2_4_2","first-page":"5","volume":"69","year":"1987","unstructured":"Manoussakis MN, Tzioufas AG, Silis MP, Pange PJE, Goudevenos J, Moutsopoulos HM. High prevalence of anticardiolipin and other autoantibodies in a healthy elderly population. Clin Exp Immunol 1987;69:557-565.","journal-title":"Clin Exp Immunol"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.410380102"},{"key":"e_1_3_2_6_2","first-page":"3","volume":"25","year":"1994","unstructured":"Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke 1994;25:333-337.","journal-title":"Stroke"},{"key":"e_1_3_2_7_2","first-page":"9","volume":"25","year":"1994","unstructured":"Lai SM, Alter M, Friday G, Sobel E. A multifactorial analysis of risk factors for recurrence of ischemic stroke. Stroke 1994;25:958-962.","journal-title":"Stroke"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1212\/WNL.40.1.1"},{"key":"e_1_3_2_9_2","first-page":"3","volume":"117","year":"1992","unstructured":"Rosove MH, Brewer PMC. Antiphospholipid thrombosis: clinical course after the first thrombotic event in 70 patients. Ann Intern Med 1992;117:303-308.","journal-title":"Ann Intern Med"},{"key":"e_1_3_2_10_2","first-page":"8","volume":"90","year":"1994","unstructured":"Tohgi H, Takahashi H, Kashiwaya M, Watanabe K, Hayama K. The anticardiolipin antibody in elderly stroke patients: its effects on stroke types, recurrence, and the coagulation-fibrinolysis system. Acta Neurol Scand 1994;90:86-90.","journal-title":"Acta Neurol Scand"},{"key":"e_1_3_2_11_2","first-page":"2","volume":"25","year":"1994","unstructured":"Montalban J, Rio J, Khamastha M, et al. Value of immunologic testing in stroke patients. A prospective multicenter study. Stroke 1994;25:2412-2415.","journal-title":"Stroke"},{"key":"e_1_3_2_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(94)91041-3"},{"key":"e_1_3_2_13_2","doi-asserted-by":"crossref","unstructured":"Feldmann E Levine SR. Cerebrovascular disease with antiphospholipid antibodies. Immune mechanisms significance and therapeutic options. Ann Neurol 1995;37(suppl 1):S114-S130.","DOI":"10.1002\/ana.410370712"},{"key":"e_1_3_2_14_2","unstructured":"The WARSS APASS PICSS and HAS Study Groups. The feasibility of a collaborative double-blind study using an anticoagulant: the Warfarin-Aspirin Recurrent Stroke Study (WARSS) the Antiphospholipid Antibodies and Stroke Study (APASS) the Patent Foramen Ovale in Cryptogenic Stroke Study (PICSS) and the Hemostatic System Activation Study (HAS). Cerebrovasc Dis (in press)."}],"container-title":["Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.neurology.org\/doi\/pdfdirect\/10.1212\/WNL.48.1.91","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T10:06:23Z","timestamp":1711533983000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.neurology.org\/doi\/10.1212\/WNL.48.1.91"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1997,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1997,1]]}},"alternative-id":["10.1212\/WNL.48.1.91"],"URL":"https:\/\/doi.org\/10.1212\/wnl.48.1.91","relation":{},"ISSN":["0028-3878","1526-632X"],"issn-type":[{"value":"0028-3878","type":"print"},{"value":"1526-632X","type":"electronic"}],"subject":[],"published":{"date-parts":[[1997,1]]}}}